These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 29656183)

  • 21. Baohuoside-1 targeting mTOR inducing apoptsis to inhibit hepatocellular carcinoma proliferation, invasion and migration.
    Guo Y; Zhu H; Weng M; Chen B; Wang C; Sun L
    Biomed Pharmacother; 2020 Aug; 128():110366. PubMed ID: 32526459
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Saponins isolated from Schizocapsa plantaginea inhibit human hepatocellular carcinoma cell growth in vivo and in vitro via mitogen-activated protein kinase signaling.
    Sun YW; Qiu HC; Ou MC; Chen RL; Liang G
    Chin J Nat Med; 2018 Jan; 16(1):29-40. PubMed ID: 29425588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hispidulin, a small flavonoid molecule, suppresses the angiogenesis and growth of human pancreatic cancer by targeting vascular endothelial growth factor receptor 2-mediated PI3K/Akt/mTOR signaling pathway.
    He L; Wu Y; Lin L; Wang J; Wu Y; Chen Y; Yi Z; Liu M; Pang X
    Cancer Sci; 2011 Jan; 102(1):219-25. PubMed ID: 21087351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Curcumin inhibits the proliferation and invasiveness of MHCC97-H cells via p38 signaling pathway.
    Zhang K; Rui X; Yan X
    Drug Dev Res; 2014 Nov; 75(7):463-8. PubMed ID: 25195681
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autophagy induction by xanthoangelol exhibits anti-metastatic activities in hepatocellular carcinoma.
    Yang X; Xie J; Liu X; Li Z; Fang K; Zhang L; Han M; Zhang Z; Gong Z; Lin X; Shi X; Gao H; Lu K
    Cell Biochem Funct; 2019 Apr; 37(3):128-138. PubMed ID: 30883849
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peroxisome proliferator-activated receptor-γ activation inhibits hepatocellular carcinoma cell invasion by upregulating plasminogen activator inhibitor-1.
    Pang X; Wei Y; Zhang Y; Zhang M; Lu Y; Shen P
    Cancer Sci; 2013 Jun; 104(6):672-80. PubMed ID: 23461356
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fucoidan-induced ID-1 suppression inhibits the in vitro and in vivo invasion of hepatocellular carcinoma cells.
    Cho Y; Cho EJ; Lee JH; Yu SJ; Kim YJ; Kim CY; Yoon JH
    Biomed Pharmacother; 2016 Oct; 83():607-616. PubMed ID: 27459117
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pioglitazone, a PPARγ agonist, inhibits growth and invasion of human hepatocellular carcinoma via blockade of the rage signaling.
    Yang Y; Zhao LH; Huang B; Wang RY; Yuan SX; Tao QF; Xu Y; Sun HY; Lin C; Zhou WP
    Mol Carcinog; 2015 Dec; 54(12):1584-95. PubMed ID: 25307746
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ψ-Bufarenogin, a novel anti-tumor compound, suppresses liver cancer growth by inhibiting receptor tyrosine kinase-mediated signaling.
    Ding J; Wen W; Xiang D; Yin P; Liu Y; Liu C; He G; Cheng Z; Yin J; Sheng C; Zhang W; Nan F; Ye W; Zhang X; Wang H
    Oncotarget; 2015 May; 6(13):11627-39. PubMed ID: 25890498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of Bim expression contributes to the antitumor synergy between sorafenib and mitogen-activated protein kinase/extracellular signal-regulated kinase kinase inhibitor CI-1040 in hepatocellular carcinoma.
    Ou DL; Shen YC; Liang JD; Liou JY; Yu SL; Fan HH; Wang DS; Lu YS; Hsu C; Cheng AL
    Clin Cancer Res; 2009 Sep; 15(18):5820-8. PubMed ID: 19737956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and in vivo cytotoxicity of troglitazone in pancreatic cancer.
    Fujita M; Hasegawa A; Yamamori M; Okamura N
    J Exp Clin Cancer Res; 2017 Jul; 36(1):91. PubMed ID: 28673319
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Teroxirone suppresses growth and motility of human hepatocellular carcinoma cells.
    Kim SH; Wang WH; Wang JP; Hsieh CH; Fang K
    Biomed Pharmacother; 2018 Mar; 99():997-1008. PubMed ID: 29653488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of peroxisome proliferator-activated receptor-gamma inhibits tumor growth by negatively regulating nuclear factor-κB activation in patients with hepatocellular carcinoma.
    Nojima H; Kuboki S; Shinoda K; Shimizu H; Ohtsuka M; Kato A; Yoshitomi H; Furukawa K; Takayashiki T; Miyazaki M
    J Hepatobiliary Pancreat Sci; 2016 Sep; 23(9):574-84. PubMed ID: 27451128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Isomalto oligosaccharide sulfate inhibits tumor growth and metastasis of hepatocellular carcinoma in nude mice.
    Xiao CL; Tao ZH; Guo L; Li WW; Wan JL; Sun HC; Wang L; Tang ZY; Fan J; Wu WZ
    BMC Cancer; 2011 Apr; 11():150. PubMed ID: 21513518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. microRNA-448 inhibits stemness maintenance and self-renewal of hepatocellular carcinoma stem cells through the MAGEA6-mediated AMPK signaling pathway.
    Guo JC; Yang YJ; Zhang JQ; Guo M; Xiang L; Yu SF; Ping H; Zhuo L
    J Cell Physiol; 2019 Dec; 234(12):23461-23474. PubMed ID: 31232474
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pentoxifylline induces apoptosis of HepG2 cells by reducing reactive oxygen species production and activating the MAPK signaling.
    Wang Y; Dong L; Li J; Luo M; Shang B
    Life Sci; 2017 Aug; 183():60-68. PubMed ID: 28583366
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Berberine suppresses Id-1 expression and inhibits the growth and development of lung metastases in hepatocellular carcinoma.
    Tsang CM; Cheung KC; Cheung YC; Man K; Lui VW; Tsao SW; Feng Y
    Biochim Biophys Acta; 2015 Mar; 1852(3):541-51. PubMed ID: 25496992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chelerythrine Inhibits Human Hepatocellular Carcinoma Metastasis in Vitro.
    Zhu Y; Pan Y; Zhang G; Wu Y; Zhong W; Chu C; Qian Y; Zhu G
    Biol Pharm Bull; 2018 Jan; 41(1):36-46. PubMed ID: 29093327
    [TBL] [Abstract][Full Text] [Related]  

  • 39. VSP‑17 suppresses the migration and invasion of triple‑negative breast cancer cells through inhibition of the EMT process via the PPARγ/AMPK signaling pathway.
    Xu X; Liu M; Yang Y; Wei C; Zhang X; Song H; Wang Y; Duan X
    Oncol Rep; 2021 Mar; 45(3):975-986. PubMed ID: 33650675
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel small-molecule compound targeting CD147 inhibits the motility and invasion of hepatocellular carcinoma cells.
    Fu ZG; Wang L; Cui HY; Peng JL; Wang SJ; Geng JJ; Liu JD; Feng F; Song F; Li L; Zhu P; Jiang JL; Chen ZN
    Oncotarget; 2016 Feb; 7(8):9429-47. PubMed ID: 26882566
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.